Concepedia

Gaoxiang Ai

GA

Statistics

Publications

13

Citations

707

H-Index

12

Active since

2019

Affiliations

Guangzhou University of Chinese Medicine(Current)

Guangdong Provincial Hospital of Traditional Chinese Medicine

First Affiliated Hospital of Guangzhou University of Chinese Medicine

University of Macau

Guangdong Pharmaceutical University

Gaoxiang Ai is an author at Guangzhou University of Chinese Medicine specializing in pharmacology, inflammation, and medicine.

Publications per year

2019–2023

13

Publications

13

Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway

Cailan Li, Gaoxiang Ai, Yongfu Wang et al. · Pharmacological Research · 2019 · 255 citations

, , +17

Palmatine Protects Against MSU-Induced Gouty Arthritis via Regulating the NF-κB/NLRP3 and Nrf2 Pathways

Juanjuan Cheng, Xingdong Ma, Gaoxiang Ai et al. · Drug Design Development and Therapy · 2022 · 91 citations · Full text

, , +17

Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signaling pathways

Yaoxing Dou, Ronglei Huang, Qiaoping Li et al. · Biomedicine & Pharmacotherapy · 2021 · 86 citations · Full text

, , +15

Patchouli oil ameliorates 5-fluorouracil-induced intestinal mucositis in rats via protecting intestinal barrier and regulating water transport

Yuxuan Gan, Gaoxiang Ai, Jiazhen Wu et al. · Journal of Ethnopharmacology · 2019 · 52 citations

, , +17

Dihydroberberine, a hydrogenated derivative of berberine firstly identified in Phellodendri Chinese Cortex, exerts anti-inflammatory effect via dual modulation of NF-κB and MAPK signaling pathways

Lihua Tan, Yongfu Wang, Gaoxiang Ai et al. · International Immunopharmacology · 2019 · 41 citations · Full text

, , +12

1–5 of 13